Drug intelligence / Profile preview

Novel Tuberculosis Vaccine (Wuxi Royal Biological)

Development stage: Preclinical
Lead developer: 罗益
Modality: Vaccines & Immunotherapeutics

Overview

The Novel Tuberculosis Vaccine is an experimental immunotherapeutic agent being developed by Wuxi Royal Biological in collaboration with the Chinese Center for Disease Control and Prevention (China CDC), specifically the Institute for Infectious Disease Prevention and Control. Currently in the preclinical stage, this vaccine is designed to prevent or treat tuberculosis (TB) infections caused by *Mycobacterium tuberculosis*. While specific details regarding its technological platform—such as whether it is a protein subunit, viral vector, or nucleic acid-based vaccine—have not been publicly disclosed, the project is a key component of Wuxi Royal Biological's research and development pipeline aimed at addressing the global health challenge of TB.

Other names: 结核病新型疫苗TB vaccine (novel)

Beyond the preview

Go deeper on Novel Tuberculosis Vaccine (Wuxi Royal Biological).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel Tuberculosis Vaccine (Wuxi Royal Biological).

Explore the full profile